Viewing Study NCT00100256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-04-22 @ 10:05 PM
Study NCT ID: NCT00100256
Status: UNKNOWN
Last Update Posted: 2022-11-07
First Post: 2004-12-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Sponsor: Andarix Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Neoplasms View
None Carcinoma, Non-Small-Cell Lung View
None Carcinoma, Small Cell View
None Neoplasm Recurrence, Local View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced or recurrent stage IIIb or IV non small cell … View
None Disseminated or recurrent small cell lung cancer View